Anixa Biosciences, Inc. (ANIX)
NASDAQ: ANIX · IEX Real-Time Price · USD
2.970
+0.030 (1.02%)
Jul 22, 2024, 9:50 AM EDT - Market open
Anixa Biosciences Employees
As of October 31, 2023, Anixa Biosciences had 5 total employees, including 4 full-time and 1 part-time employees. The number of employees did not change compared to the previous year.
Employees
5
Change (1Y)
n/a
Growth (1Y)
n/a
Revenue / Employee
n/a
Profits / Employee
-$2,319,000
Market Cap
94.10M
Employees Chart
Related Stocks
Company Name | Employees |
---|---|
111, Inc. | 1,520 |
LakeShore Biopharma | 773 |
Xtant Medical Holdings | 215 |
Asensus Surgical | 209 |
Omega Therapeutics | 94 |
Aclaris Therapeutics | 91 |
Assembly Biosciences | 65 |
Sensus Healthcare | 35 |
ANIX News
- 5 days ago - Anixa Biosciences Announces Japanese Patent on Breast Cancer Vaccine Technology - PRNewsWire
- 7 days ago - Anixa Biosciences Announces $5 Million Share Repurchase Program - PRNewsWire
- 4 weeks ago - Anixa Biosciences Treats Sixth Patient in its Ovarian Cancer CAR-T Clinical Trial - PRNewsWire
- 2 months ago - Anixa Biosciences Commences Treatment of Fifth Patient in Ovarian Cancer CAR-T Clinical Trial - PRNewsWire
- 2 months ago - Anixa Biosciences Expands Partnership with Cleveland Clinic to Develop Additional Cancer Vaccines - PRNewsWire
- 2 months ago - Anixa Biosciences CEO Featured on "Target: Cancer Podcast" by Oncologist Dr. Sanjay Juneja - PRNewsWire
- 2 months ago - Anixa Biosciences to Participate in the Sidoti Micro-Cap Virtual Conference on May 8 & 9, 2024 - PRNewsWire
- 3 months ago - Anixa Biosciences Welcomes Celebrity Oncologist Dr. Sanjay Juneja to its Cancer Business Advisory Board - PRNewsWire